Natixis Advisors, L.P. West Pharmaceutical Services Inc Transaction History
Natixis Advisors, L.P.
- $63 Billion
- Q2 2025
A detailed history of Natixis Advisors, L.P. transactions in West Pharmaceutical Services Inc stock. As of the latest transaction made, Natixis Advisors, L.P. holds 56,362 shares of WST stock, worth $15 Million. This represents 0.02% of its overall portfolio holdings.
Number of Shares
56,362
Previous 59,476
5.24%
Holding current value
$15 Million
Previous $13.3 Million
7.38%
% of portfolio
0.02%
Previous 0.02%
Shares
30 transactions
Others Institutions Holding WST
# of Institutions
820Shares Held
68.6MCall Options Held
344KPut Options Held
144K-
Vanguard Group Inc Valley Forge, PA9.32MShares$2.48 Billion0.03% of portfolio
-
Black Rock Inc. New York, NY7.58MShares$2.02 Billion0.06% of portfolio
-
State Street Corp Boston, MA3.27MShares$870 Million0.03% of portfolio
-
Brown Advisory Inc3.02MShares$804 Million0.92% of portfolio
-
Artisan Partners Limited Partnership Milwaukee, WI2.2MShares$584 Million0.85% of portfolio
About WEST PHARMACEUTICAL SERVICES INC
- Ticker WST
- Exchange NYSE
- Sector Healthcare
- Industry Medical Instruments & Supplies
- Shares Outstandng 74,033,000
- Market Cap $19.7B
- Description
- West Pharmaceutical Services, Inc. designs, manufactures, and sells containment and delivery systems for injectable drugs and healthcare products in the Americas, Europe, the Middle East, Africa, and the Asia Pacific. It operates in two segments, Proprietary Products and Contract-Manufactured Products. The Proprietary Products segment offers sto...